Research & Development: Page 59
-
PharmaVoice Team/PharmaVoice
Can We Make Monitoring Better? That's the $5 Billion Question.
Incredibly, only 6 percent of new pharmaceutical products ever recoup their development costs. Any other industry would simply cease production of such an unprofitable venture. But we don’t have that luxury. We need to change the way we do things and reduce resource-sapping redundancies. And that...
By Amy Kissam • May 29, 2013 -
PharmaVoice Team/PharmaVoice
This Old House: Conducting A Clinical Trial Energy Audit
Our local utility company offers free “energy audits." An auditor will check the robustness of your heating, ventilation, and air conditioning (HVAC) systems and examine your home’s physical envelope — walls, floors, windows, doors — to assess it for leaks. When you live in New England (cold wint...
By Denise Derenzo Lacey • May 29, 2013 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Clinical Transformation: More Than A Solution It's A New Way To Work
To succeed in today’s global competitive market, drug companies need to innovate and pursue efficient ways of conducting clinical trials to shorten cycle times and achieve cost savings. As an answer to these new challenges, companies need an integrated and holistic solution based on process optim...
By Bhaskar Sambbasivan • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence Improves Pharma Efficiency
As I consult with clients, I see that technology will ultimately be the driver behind pharmaceutical and biotechnology advancements in the coming decade. I believe that the use of artificial intelligence (AI) is a prime example of innovative efficiencies to come. More than 15 years ago, when I wa...
By G. Steven Geis • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Monitoring Cardiac Safety: Minimizing Risk For Your Next Clinical Trial
Many drugs used to treat non-cardiac conditions are known to have off-target cardiovascular effects including arrhythmias, hypertension, and reduced ventricular function, which may lead to increased cardiac risk and possibly death. This presents a major challenge not only for clinicians who admin...
By Mark Weinstein • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Electronic Patient Reported Outcomes and Integrated Systems: Effective Solutions for Enhanced Compliance and High Data Quality
With all the elements that comprise a clinical trial — from design to enrollment to analysis — it is little wonder that success can be impeded by challenges along the way. Use of Electronic Patient Reported Outcome Technologies Low patient compliance and low data quality of Patient Reported Outco...
By Valarie Higgins • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Innovative Israel Creates Pharma Opportunity
The state of Israel is one of the most advanced economies in the southwest Asia region, and is rated 38th out of 185 nations worldwide on the World Bank’s Ease of Doing Business Index. Often described as a start-up nation, Israel hosts more NASDAQ-listed companies per citizen than any other count...
By Kim Ribbink • May 29, 2013 -
PharmaVoice Team/PharmaVoice
2013 DIA Preview
2013 DIA Preview This year’s theme: Advancing Therapeutic Innovation and Regulatory Science. The Drug Information Association’s 49th Annual Meeting will be held June 23 to 27 at the Boston Convention & Exhibition Center. There will be more than 250 sessions covering 22 tracks on hot topics fr...
By Taren Grom • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Adapting to Adaptive Drug Development
The promise of cost-savings associated with adaptive clinical trials is an attractive one. Many drug companies have already put in place trials that use some type of adaptive designs. But most times, companies implement adaptive trial design experimentally, mitigating risk by applying it only dur...
By Denise Myshko • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Last Word
Global Trade Organization Amplifies Sites’ Voice Christine pierre, President of RxTrials, takes the helm of the Society for Clinical Research Sites (SCRS) after forming the organization to help sites raise their voice with sponsors, CROs, and other clinical stakeholders. The LAST Word PV: What wa...
By Christine Pierre • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Dr. Lynn KRAMER Eisai Creates New Chief Clinical Officer Position Eisai, the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has appointed Lynn Kramer, M.D., to the newly created position of chief clinical officer of Eisai Product Creation Systems. In this role, Dr. Kramer is respo...
By Ann Grey • May 29, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
June 17-18 Gross to Net Accounting Forum for Pharmaceutical Manufacturers Hyatt Harbor Side, Boston Institute for International Research, iirusa.comJune 17-19 Next-Gen Kinase Inhibitors The Revere Hotel, Boston Cambridge Healthtech Institute, healthtech.com/kin/ June 18 5th Annual Cloud Slam 2013...
By Heather Hummel • May 29, 2013 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: GSW Launches Health Experience Project Teva Establishes Global Specialty Medicines Group Sidebars: On the Shelves AROUND THE GLOBE New 360 Corporate Compliance Program for the Life-Sciences Industry Weber Shandwick Launch...
By Ann Grey • May 29, 2013 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Strategic Partnerships Provide Value Engaging Digital Patients Can Foster Biopharma Product Development Use of Digital Marketing Channels to Increase Sidebars: Impact of Strategic Partnerships Key Findings in...
By Denise Myshko • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Tools of the Trade Collaboration Suite Moves Research Networks to the Cloud Trending Now: Cloud-based systems can facilitate technology transfer, collaboration, and scientific informatics in externalized life-sciences partner networks. Accelrys has launched a software solution — Externalized Coll...
By Denise Myshko • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Your Teachable Moment is Now
One of your sales organization’s biggest challenges is to develop and nurture an ongoing learning environment for field reps. Your goal is to make every rep as good as your best rep by providing tools and training that raise the playing field to its highest level. The secret lies in continuous, c...
By Jay Goldman • April 26, 2013 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Training: A New Way Forward
Jay Goldman Senior VP Innovation Klick Health Training in the Moment Reps need to be provided with ongoing, in-the-moment training, served up in small bite-sized snippets. These are then put into practice immediately, shortening the time gap between learning and execution and reinforcing lessons...
By Taren Grom • April 26, 2013 -
PharmaVoice Team/PharmaVoice
South Africa: Wealth Disparity versus Pharma Opportunity
According to Zane Wilson, founder of the South African Depression and Anxiety Group, with the recent global recession, poor households have sunk deeper into poverty and many more South Africans are finding themselves steeped in financial woes. One in five South Africans may suffer from a mental d...
By Kim Ribbink • April 26, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
May 16-17 Thought Leader Engagement, the Role of Medical Affairs and Medical Science Liaisons in the Era of Healthcare Reform Hyatt at the Bellevue, Philadelphia World Congress, worldcongress.com May 20-21 2nd Annual Quality Assurance in Pharmaceutical Manufacturing Conference Alexandria, Va. Q1...
By Heather Hummel • April 26, 2013 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D?Trends affecting the healthcare industry Mobile Health is Poised for Growth Trending Now: As the use of technology increases, particularly smartphones, it is more important than ever for life-sciences companies to reach patients beyond the point of care t...
By Denise Myshko • April 26, 2013 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: QuantiaMD Launches Digital Marketing Strategies Solution E-UPGRADES AND ENHANCEMENTS Oracle Launches Mobile Clinical Research Associate AG Mednet Announces Cloud Storage Solution Tools of the Trade Denise Myshko T...
By Denise Myshko • April 26, 2013 -
PharmaVoice Team/PharmaVoice
UpFront
UpFront Podcasts Value of a Credential in the Medical Publications Profession Thought Leader: Stacy Simpson Logan, CMPP Board of Trustees, and Waterfall Consulting What is Creativity? Thought Leader: Anthony Rotolo, True Health + Wellness New Challenges for Global Clinical Trials: Managing Suppl...
By Denise Myshko • April 25, 2013 -
PharmaVoice Team/PharmaVoice
C-Suite: CROs
CROs: Integrated Outsourcing Growth Opportunities Ahead The global R&D outsourcing market by 2018 is expected to be 37.1% of the total pharmaceutical R&D expenditure compared with 25.3% in 2010. In GBI Research’s latest report, Contract Research Organizations (CROs) Market to 2018 — Publi...
By Taren Grom • March 28, 2013 -
PharmaVoice Team/PharmaVoice
Singapore's Strong Economy Creates Pharma Opportunity
Singapore’s Strong Economy Creates Pharma Opportunity With its developed world economy and strong government support for innovation and business, Singapore offers a healthy environment for life-sciences companies to conduct research, development, and manufacturing. By Kim Ribbink Singapore is a S...
By Kim Ribbink • March 28, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Dr. John REED Roche Corporate Executive Committee Appoints Head Roche has apointed John Reed, M.D., Ph.D., as head of Roche Pharma Research and Early Development (pRED) and member of the corporate executive committee. Dr. Reed earned his M.D. and Ph.D. at the School of Medicine of the...
By Ann Grey • March 28, 2013
Previous
